Abstract
Acral erythema (AE) and eccrine squamous syringometaplasia (ESS) are distinctive clinico-pathological entities described in patients receiving chemotherapy for malignancies, mainly myelogenous leukemia. In no case of chemotherapy-induced AE have histopathologic changes of ESS been described. We report a patient with acute myelogenous leukemia who had typical AE due to cytarabine with histopathologic ESS. The latter findings in a case of AE may be a useful diagnostic clue for distinguishing chemotherapy-induced AE from palmo-plantar erythema of graft-vs-host reaction.
| Original language | English |
|---|---|
| Pages (from-to) | 453-456 |
| Number of pages | 4 |
| Journal | Journal of Cutaneous Pathology |
| Volume | 18 |
| Issue number | 6 |
| Publication status | Published - 1991 |
ASJC Scopus subject areas
- Dermatology
- Pathology and Forensic Medicine
Fingerprint Dive into the research topics of 'Necrotizing eccrine squamous syringometaplasia presenting as acral erythema'. Together they form a unique fingerprint.
Cite this
Rongioletti, F., Ballestrero, A., Bogliolo, F., & Rebora, A. (1991). Necrotizing eccrine squamous syringometaplasia presenting as acral erythema. Journal of Cutaneous Pathology, 18(6), 453-456.